Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Presentation, Diagnosis, and Special Populations
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
Pediatric Dermatology
|
July 6, 2019
Pediatric leukemia cutis: A case series
Elena Corina Andriescu, Carrie C Coughlin, Carol E Cheng, et al.
JAMA Dermatology
|
March 12, 2015
Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations
Oyinade M Aderibigbe, Debra Long Priel, Chyi-Chia Richard Lee, et al.
Journal of the American Academy of Dermatology
|
May 25, 2023
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
Andrew Blauvelt, Barry Ladizinski, Vimal H Prajapati, et al.
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Epidemiology, Burden of Disease, and Pathophysiology
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
Journal of the American Academy of Dermatology
|
June 17, 2024
Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective study
Siddhartha Sood, Alexander Rimke, Brian D Rankin, et al.
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Treatment Options
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
The British Journal of Dermatology
|
June 28, 2025
Efficacy and Safety of Upadacitinib Dose Escalation and Reduction in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results of a Randomized, Blinded, Treat-To-Target, Multicenter Phase 3b/4 Study (Flex Up)
Melinda Gooderham, Tiago Torres, Shinichi Imafuku, et al.
Journal of the American Academy of Dermatology
|
July 25, 2024
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
Brett King, Maryanne M Senna, Natasha A Mesinkovska, et al.
Journal of Cutaneous Medicine and Surgery
|
November 7, 2019
Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section IV: Consensus Statements on the Assessment and Management of Pediatric Atopic Dermatitis
Perla Lansang, Irene Lara-Corrales, James N Bergman, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Presentation, Diagnosis, and Special Populations
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
Pediatric Dermatology
|
July 6, 2019
Pediatric leukemia cutis: A case series
Elena Corina Andriescu, Carrie C Coughlin, Carol E Cheng, et al.
JAMA Dermatology
|
March 12, 2015
Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations
Oyinade M Aderibigbe, Debra Long Priel, Chyi-Chia Richard Lee, et al.
Journal of the American Academy of Dermatology
|
May 25, 2023
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)
Andrew Blauvelt, Barry Ladizinski, Vimal H Prajapati, et al.
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Epidemiology, Burden of Disease, and Pathophysiology
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
Journal of the American Academy of Dermatology
|
June 17, 2024
Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective study
Siddhartha Sood, Alexander Rimke, Brian D Rankin, et al.
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Treatment Options
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
The British Journal of Dermatology
|
June 28, 2025
Efficacy and Safety of Upadacitinib Dose Escalation and Reduction in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results of a Randomized, Blinded, Treat-To-Target, Multicenter Phase 3b/4 Study (Flex Up)
Melinda Gooderham, Tiago Torres, Shinichi Imafuku, et al.
Journal of the American Academy of Dermatology
|
July 25, 2024
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
Brett King, Maryanne M Senna, Natasha A Mesinkovska, et al.
Journal of Cutaneous Medicine and Surgery
|
November 7, 2019
Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section IV: Consensus Statements on the Assessment and Management of Pediatric Atopic Dermatitis
Perla Lansang, Irene Lara-Corrales, James N Bergman, et al.
Page
of 11